<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="f6eba4b6-9cd0-4c86-46a8-05a202641c89"><labelDrug name="DYAZIDE"><Normalization><mmtx cui="C0058829" preferredWord="Dyazide" semType="phsu, orch"/></Normalization></labelDrug><generic name="hydrochlorothiazide and triamterene"/><sentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.1" text="Drug Label for drug brand DYAZIDE, containing hydrochlorothiazide and triamterene." type="negative"><entity charOffset="0:19" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.1.e.0" text="drug drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0013231" phraseText="Drug Label for drug brand DYAZIDE," preferredWord="Drugs, Non-Prescription" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="26:33" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.1.e.1" text="dyazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0058829" phraseText="Drug Label for drug brand DYAZIDE," preferredWord="Dyazide" semType="phsu, orch"/><RxNorm RxCui="23742"/></Normalization></entity><entity charOffset="70:81" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.1.e.2" text="triamterene" type="Biomedical_Entity"><Normalization><mmtx cui="C0040869" phraseText="triamterene." preferredWord="Triamterene" semType="phsu, orch"/><RxNorm RxCui="10763"/></Normalization></entity><entity charOffset="46:65" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.1.e.3" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.1.e.0" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.1.e.1"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.1.e.0" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.1.e.2"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.1.e.0" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.1.e.3"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.1.e.1" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.1.e.2"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.1.e.1" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.1.e.3"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.1.e.3" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.1.e.2"/></sentence><sentence biomedicalEntities="5" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.4" lineNumber="10" text="DYAZIDE should not be given to patients receiving other potassium-sparing agents such as spironolactone, amiloride, or other formulations containing triamterene. " type="regular"><entity charOffset="56:80" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.4.e.1" text="potassium-sparing agents" type="Drug_Class"><Normalization><mmtx cui="C0597277" phraseText="other potassium-sparing agents such as spironolactone," preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C1254351" phraseText="other potassium-sparing agents such as spironolactone," preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="1437061"/></Normalization></entity><entity charOffset="89:103" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.4.e.2" text="spironolactone" type="Drug"><Normalization><mmtx cui="C0037982" phraseText="other potassium-sparing agents such as spironolactone," preferredWord="Spironolactone" semType="strd, phsu"/><RxNorm RxCui="9997"/></Normalization></entity><entity charOffset="105:114" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.4.e.4" text="amiloride" type="Drug"><Normalization><mmtx cui="C0002502" phraseText="amiloride," preferredWord="Amiloride" semType="phsu, orch"/><RxNorm RxCui="142424"/></Normalization></entity><entity charOffset="15:27" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.4.e.6" text="not be given" type="Caution_Interaction"/><entity charOffset="125:161" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.4.e.7" text="formulations containing triamterene." type="Drug_Class"><Normalization><mmtx cui="C0040869" phraseText="triamterene." preferredWord="Triamterene" semType="phsu, orch"/><RxNorm RxCui="217195"/></Normalization></entity><entity charOffset="0:7" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.4.e.8" text="DYAZIDE" type="Drug"><Normalization><mmtx cui="C0058829" phraseText="DYAZIDE" preferredWord="Dyazide" semType="phsu, orch"/><RxNorm RxCui="23742"/></Normalization></entity><drugClassMembership drug="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.4.e.2" drugClass="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.4.e.1"/><drugClassMembership drug="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.4.e.4" drugClass="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.4.e.1"/><drugInteraction id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.4.ddi.1"><interaction trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.4.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.4.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.4.e.7"/></relation><relation type="hasObject"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.4.e.8"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.4.e.8" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.4.e.1" trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.4.e.6" type="Caution_Interaction"/><pair ddi="true" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.4.e.8" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.4.e.7" trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.4.e.6" type="Caution_Interaction"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.4.e.1" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.4.e.7"/></sentence><sentence biomedicalEntities="1" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.5" lineNumber="10" text="Concomitant potassium-containing salt substitutes should also not be used." type="irregular"><entity charOffset="62:73" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.5.e.1" text="not be used" type="Caution_Interaction"/><entity charOffset="12:49" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.5.e.2" text="potassium-containing salt substitutes" type="Substance"><Normalization><mmtx cui="C0597277" phraseText="Concomitant potassium-containing salt substitutes" preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C0784217" phraseText="Concomitant potassium-containing salt substitutes" preferredWord="Salt Substitute" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><drugInteraction id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.5.ddi.1"><interaction trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.5.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.5.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.4" text="DYAZIDE should not be given to patients receiving other potassium-sparing agents such as spironolactone, amiloride, or other formulations containing triamterene. "><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.4.e.8"/></ellipsisSentence></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.5.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.6" lineNumber="11" text="Potassium supplementation should not be used with DYAZIDE except in severe cases of hypokalemia. " type="regular"><entity charOffset="33:44" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.6.e.1" text="not be used" type="Caution_Interaction"/><entity charOffset="0:25" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.6.e.2" text="Potassium supplementation" type="Drug_Class"><Normalization><mmtx cui="C0561938" phraseText="Potassium supplementation" preferredWord="Potassium supplementation" semType="phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="50:57" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.6.e.3" text="DYAZIDE" type="Drug"><Normalization><mmtx cui="C0058829" phraseText="used with DYAZIDE" preferredWord="Dyazide" semType="phsu, orch"/><RxNorm RxCui="23742"/></Normalization></entity><drugInteraction id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.6.ddi.1"><interaction trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.6.e.1"><relations><relation type="hasObject"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.6.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.6.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.6.e.2" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.6.e.3" trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.6.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="0" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.7" lineNumber="11" text="Such concomitant therapy can be associated with rapid increases in serum potassium levels. " type="irregular"><entity charOffset="54:89" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.7.e.1" text="increases in serum potassium levels" type="Specific_Interaction"/><drugInteraction id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.7.ddi.1"><interaction trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.7.e.1"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.6" text="Potassium supplementation should not be used with DYAZIDE except in severe cases of hypokalemia. "><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.6.e.2"/></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.6" text="Potassium supplementation should not be used with DYAZIDE except in severe cases of hypokalemia. "><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.6.e.3"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="1" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.8" lineNumber="11" text="If potassium supplementation is used, careful monitoring of the serum potassium level is necessary." type="irregular"><entity charOffset="46:56" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.8.e.1" text="monitoring" type="Caution_Interaction"/><entity charOffset="3:28" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.8.e.2" text="potassium supplementation" type="Drug_Class"><Normalization><mmtx cui="C0561938" phraseText="potassium supplementation" preferredWord="Potassium supplementation" semType="phsu"/><RxNorm RxCui="8588"/></Normalization></entity><drugInteraction id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.8.ddi.1"><interaction trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.8.e.1"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.6" text="Potassium supplementation should not be used with DYAZIDE except in severe cases of hypokalemia. "><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.6.e.3"/></ellipsisSentence><middleSentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.7" text="Such concomitant therapy can be associated with rapid increases in serum potassium levels. "/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.8.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.8.e.2"/></sentence><sentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.14" text="DYAZIDE should not be used in patients with preexisting elevated serum potassium." type="negative"><entity charOffset="71:80" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.14.e.0" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="with preexisting elevated serum potassium." preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="0:7" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.14.e.1" text="dyazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0058829" phraseText="DYAZIDE" preferredWord="Dyazide" semType="phsu, orch"/><RxNorm RxCui="23742"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.14.e.1" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.14.e.0"/></sentence><sentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.16" text="Hyperkalemia: Abnormal elevation of serum potassium levels (greater than or equal to 5.5 mEq/liter) can occur with all potassium-sparing diuretic combinations, including DYAZIDE. " type="negative"><entity charOffset="119:145" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.16.e.0" text="potassium-sparing diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C3536751" phraseText="occur with all potassium-sparing diuretic combinations," preferredWord="Potassium-sparing Diuretic [EPC]" semType="phsu"/><RxNorm RxCui="1437061"/></Normalization></entity><entity charOffset="42:51" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.16.e.1" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="Abnormal elevation of serum potassium levels" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="170:177" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.16.e.2" text="dyazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0058829" phraseText="DYAZIDE." preferredWord="Dyazide" semType="phsu, orch"/><RxNorm RxCui="23742"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.16.e.1" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.16.e.0"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.16.e.0" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.16.e.2"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.16.e.1" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.16.e.2"/></sentence><sentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.18" text="Since uncorrected hyperkalemia may be fatal, serum potassium levels must be monitored at frequent intervals especially in patients first receiving DYAZIDE, when dosages are changed or with any illness that may influence renal function." type="negative"><entity charOffset="147:154" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.18.e.0" text="dyazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0058829" phraseText="in patients first receiving DYAZIDE," preferredWord="Dyazide" semType="phsu, orch"/><RxNorm RxCui="23742"/></Normalization></entity><entity charOffset="51:60" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.18.e.1" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="fatal, serum potassium levels" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.18.e.1" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.18.e.0"/></sentence><sentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.21" text="If hyperkalemia is present, DYAZIDE should be discontinued immediately and a thiazide alone should be substituted. " type="negative"><entity charOffset="28:35" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.21.e.0" text="dyazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0058829" phraseText="present, DYAZIDE" preferredWord="Dyazide" semType="phsu, orch"/><RxNorm RxCui="23742"/></Normalization></entity><entity charOffset="77:85" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.21.e.1" text="thiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="a thiazide" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.21.e.0" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.21.e.1"/></sentence><sentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.22" text="If the serum potassium exceeds 6.5 mEq/liter more vigorous therapy is required. " type="negative"><entity charOffset="13:22" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.22.e.0" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="the serum potassium" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="31:38" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.22.e.1" text="6 meq" type="Biomedical_Entity"><Normalization><mmtx cui="C0378958" phraseText="6.5 mEq/liter more vigorous therapy" preferredWord="6-methoxy-N-ethylquinolinium" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.22.e.0" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.22.e.1"/></sentence><sentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.24" text="These include the intravenous administration of calcium chloride solution, sodium bicarbonate solution, and/or the oral or parenteral administration of glucose with a rapid-acting insulin preparation. " type="negative"><entity charOffset="180:199" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.24.e.0" text="insulin preparation" type="Biomedical_Entity"><Normalization><mmtx cui="C0021641" phraseText="with a rapid-acting insulin preparation." preferredWord="Insulin" semType="phsu, aapp, horm"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="48:64" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.24.e.1" text="calcium chloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0006686" phraseText="the intravenous administration of calcium chloride solution," preferredWord="Calcium Chloride" semType="inch, phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="152:159" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.24.e.2" text="glucose" type="Biomedical_Entity"><Normalization><mmtx cui="C0017725" phraseText="parenteral administration of glucose" preferredWord="Glucose" semType="bacs, phsu, carb"/><RxNorm RxCui="4850"/></Normalization></entity><entity charOffset="75:102" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.24.e.3" text="sodium bicarbonate solution" type="Biomedical_Entity"><Normalization><mmtx cui="C2987686" phraseText="sodium bicarbonate solution," preferredWord="Sodium Bicarbonate Solution" semType="phsu"/><RxNorm RxCui="9853"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.24.e.1" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.24.e.0"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.24.e.2" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.24.e.0"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.24.e.3" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.24.e.0"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.24.e.1" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.24.e.2"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.24.e.1" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.24.e.3"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.24.e.3" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.24.e.2"/></sentence><sentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.30" text="The renal clearances of hydrochlorothiazide and the pharmacologically active metabolite of triamterene, the sulfate ester of hydroxytriamterene, have been shown to be reduced and the plasma levels increased following administration of DYAZIDE to elderly patients and patients with impaired renal function." type="negative"><entity charOffset="91:102" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.30.e.0" text="triamterene" type="Biomedical_Entity"><Normalization><mmtx cui="C0040869" phraseText="the pharmacologically active metabolite of triamterene," preferredWord="Triamterene" semType="phsu, orch"/><RxNorm RxCui="10763"/></Normalization></entity><entity charOffset="235:242" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.30.e.1" text="dyazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0058829" phraseText="administration of DYAZIDE" preferredWord="Dyazide" semType="phsu, orch"/><RxNorm RxCui="23742"/></Normalization></entity><entity charOffset="24:43" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.30.e.2" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="The renal clearances of hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.30.e.0" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.30.e.1"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.30.e.2" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.30.e.0"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.30.e.2" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.30.e.1"/></sentence><sentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.32" text="Accordingly, serum electrolytes must be frequently monitored if DYAZIDE is used in diabetic patients." type="negative"><entity charOffset="19:31" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.32.e.0" text="electrolytes" type="Biomedical_Entity"><Normalization><mmtx cui="C3536863" phraseText="serum electrolytes" preferredWord="Electrolyte [EPC]" semType="phsu"/><RxNorm RxCui="3793"/></Normalization></entity><entity charOffset="64:71" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.32.e.1" text="dyazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0058829" phraseText="DYAZIDE" preferredWord="Dyazide" semType="phsu, orch"/><RxNorm RxCui="23742"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.32.e.0" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.32.e.1"/></sentence><sentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.36" text="If DYAZIDE is employed, frequent evaluations of acid/base balance and serum electrolytes are necessary." type="negative"><entity charOffset="3:10" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.36.e.0" text="dyazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0058829" phraseText="DYAZIDE" preferredWord="Dyazide" semType="phsu, orch"/><RxNorm RxCui="23742"/></Normalization></entity><entity charOffset="76:88" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.36.e.1" text="electrolytes" type="Biomedical_Entity"><Normalization><mmtx cui="C0013832" phraseText="serum electrolytes" preferredWord="Electrolytes" semType="inch, phsu"/><RxNorm RxCui="3793"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.36.e.0" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.36.e.1"/></sentence><sentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.38" text="Hydrochlorothiazide, a sulfonamide, can cause an idiosyncratic reaction, resulting in acute transient myopia and acute angle-closure glaucoma. " type="negative"><entity charOffset="23:34" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.38.e.0" text="sulfonamide" type="Biomedical_Entity"><Normalization><mmtx cui="C0599503" phraseText="a sulfonamide," preferredWord="Sulfonamide Anti-Infective Agents" semType="orch, antb"/><RxNorm RxCui="1427600"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.38.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Hydrochlorothiazide," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.38.e.1" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.38.e.0"/></sentence><sentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.46" text="Caution should be exercised when administering DYAZIDE to patients with diabetes, since thiazides may cause hyperglycemia, glycosuria, and alter insulin requirements in diabetes. " type="negative"><entity charOffset="145:152" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.46.e.0" text="insulin" type="Biomedical_Entity"><Normalization><mmtx cui="C1533581" phraseText="insulin requirements in diabetes." preferredWord="Recombinant Insulin" semType="phsu, aapp, horm"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="88:97" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.46.e.1" text="thiazides" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="47:54" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.46.e.2" text="dyazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0058829" phraseText="administering DYAZIDE to patients" preferredWord="Dyazide" semType="phsu, orch"/><RxNorm RxCui="23742"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.46.e.1" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.46.e.0"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.46.e.2" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.46.e.0"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.46.e.2" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.46.e.1"/></sentence><sentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.55" text="Hypokalemia is uncommon with DYAZIDE, but, should it develop, corrective measures should be taken such as potassium supplementation or increased intake of potassium-rich foods. " type="negative"><entity charOffset="106:131" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.55.e.0" text="potassium supplementation" type="Biomedical_Entity"><Normalization><mmtx cui="C0561938" phraseText="taken such as potassium supplementation" preferredWord="Potassium supplementation" semType="phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="155:164" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.55.e.1" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="increased intake of potassium-rich foods." preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="29:36" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.55.e.2" text="dyazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0058829" phraseText="uncommon with DYAZIDE," preferredWord="Dyazide" semType="phsu, orch"/><RxNorm RxCui="23742"/></Normalization></entity><entity charOffset="62:72" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.55.e.3" text="corrective" type="Biomedical_Entity"><Normalization><mmtx cui="C0719519" phraseText="corrective measures" preferredWord="Corrective" semType="phsu, orch"/><RxNorm RxCui="216230"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.55.e.0" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.55.e.1"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.55.e.2" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.55.e.0"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.55.e.3" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.55.e.0"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.55.e.2" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.55.e.1"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.55.e.3" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.55.e.1"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.55.e.2" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.55.e.3"/></sentence><sentence biomedicalEntities="1" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.56" lineNumber="56" text="Institute such measures cautiously with frequent determinations of serum potassium levels, especially in patients receiving digitalis or with a history of cardiac arrhythmias. " type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.55" Text="Hypokalemia is uncommon with DYAZIDE, but, should it develop, corrective measures should be taken such as potassium supplementation or increased intake of potassium-rich foods. "/><anaphoraEntity charOffset="10:23" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.56.e.1" text="such measures" type="Expression"/><antecedentEntity charOffset="106:131" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.55.e.0" text="potassium supplementation" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.55" Text="Hypokalemia is uncommon with DYAZIDE, but, should it develop, corrective measures should be taken such as potassium supplementation or increased intake of potassium-rich foods. "/><anaphoraEntity charOffset="10:23" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.56.e.1" text="such measures" type="Expression"/><antecedentEntity charOffset="155:175" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.55.e.1" text="potassium-rich foods" type="Substance"/></anaphoraRelation><entity charOffset="24:34" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.56.e.4" text="cautiously" type="Caution_Interaction"/><entity charOffset="124:133" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.56.e.5" text="digitalis" type="Drug"><Normalization><mmtx cui="C0304520" phraseText="digitalis" preferredWord="Digitalis preparation" semType="phsu, carb"/><RxNorm RxCui="91235"/></Normalization></entity><drugInteraction id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.56.ddi.1"><interaction trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.56.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.56.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.56.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.56.e.1" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.56.e.5" trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.56.e.4" type="Caution_Interaction"/></sentence><sentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.57" text="If serious hypokalemia (serum potassium less than 3.0 mEq/L) is demonstrated by repeat serum potassium determinations, DYAZIDE should be discontinued and potassium chloride supplementation initiated. " type="negative"><entity charOffset="119:126" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.57.e.0" text="dyazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0058829" phraseText="DYAZIDE" preferredWord="Dyazide" semType="phsu, orch"/><RxNorm RxCui="23742"/></Normalization></entity><entity charOffset="93:102" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.57.e.1" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="demonstrated by repeat serum potassium determinations," preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="154:188" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.57.e.2" text="potassium supplementation" type="Biomedical_Entity"><Normalization><mmtx cui="C0561938" phraseText="potassium chloride supplementation" preferredWord="Potassium supplementation" semType="phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="30:39" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.57.e.3" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="(serum potassium less than 3.0 mEq/" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.57.e.1" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.57.e.0"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.57.e.0" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.57.e.2"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.57.e.3" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.57.e.0"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.57.e.1" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.57.e.2"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.57.e.3" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.57.e.2"/></sentence><sentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.60" text="Electrolyte imbalance, often encountered in such conditions as heart failure, renal disease or cirrhosis of the liver, may also be aggravated by diuretics and should be considered during therapy with DYAZIDE when using high doses for prolonged periods or in patients on a salt-restricted diet. " type="negative"><entity charOffset="200:207" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.60.e.0" text="dyazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0058829" phraseText="with DYAZIDE" preferredWord="Dyazide" semType="phsu, orch"/><RxNorm RxCui="23742"/></Normalization></entity><entity charOffset="0:11" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.60.e.1" text="electrolyte" type="Biomedical_Entity"><Normalization><mmtx cui="C0013832" phraseText="Electrolyte imbalance," preferredWord="Electrolytes" semType="inch, phsu"/><RxNorm RxCui="3793"/></Normalization></entity><entity charOffset="145:154" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.60.e.2" text="diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="aggravated by diuretics" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.60.e.1" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.60.e.0"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.60.e.2" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.60.e.0"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.60.e.1" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.60.e.2"/></sentence><sentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.73" text="If hypokalemia should develop, corrective measures should be taken such as potassium supplementation or increased dietary intake of potassium-rich foods." type="negative"><entity charOffset="31:41" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.73.e.0" text="corrective" type="Biomedical_Entity"><Normalization><mmtx cui="C0719519" phraseText="corrective measures" preferredWord="Corrective" semType="phsu, orch"/><RxNorm RxCui="216230"/></Normalization></entity><entity charOffset="75:100" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.73.e.1" text="potassium supplementation" type="Biomedical_Entity"><Normalization><mmtx cui="C0561938" phraseText="taken such as potassium supplementation" preferredWord="Potassium supplementation" semType="phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="132:141" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.73.e.2" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="increased dietary intake of potassium-rich foods." preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.73.e.0" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.73.e.1"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.73.e.0" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.73.e.2"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.73.e.1" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.73.e.2"/></sentence><sentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.78" text="Discontinue corrective measures for hypokalemia immediately if laboratory determinations reveal an abnormal elevation of serum potassium." type="negative"><entity charOffset="12:22" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.78.e.0" text="corrective" type="Biomedical_Entity"><Normalization><mmtx cui="C0719519" phraseText="corrective measures for hypokalemia immediately" preferredWord="Corrective" semType="phsu, orch"/><RxNorm RxCui="216230"/></Normalization></entity><entity charOffset="127:136" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.78.e.1" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="an abnormal elevation of serum potassium." preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.78.e.0" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.78.e.1"/></sentence><sentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.79" text="Discontinue DYAZIDE and substitute a thiazide diuretic alone until potassium levels return to normal." type="negative"><entity charOffset="12:19" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.79.e.0" text="dyazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0058829" phraseText="DYAZIDE" preferredWord="Dyazide" semType="phsu, orch"/><RxNorm RxCui="23742"/></Normalization></entity><entity charOffset="37:54" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.79.e.1" text="thiazide diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012802" phraseText="a thiazide diuretic" preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="67:76" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.79.e.2" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="alone until potassium levels" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.79.e.0" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.79.e.1"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.79.e.0" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.79.e.2"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.79.e.1" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.79.e.2"/></sentence><sentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.81" text="DYAZIDE may produce an elevated blood urea nitrogen level, creatinine level or both. " type="negative"><entity charOffset="0:7" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.81.e.0" text="dyazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0058829" phraseText="DYAZIDE" preferredWord="Dyazide" semType="phsu, orch"/><RxNorm RxCui="23742"/></Normalization></entity><entity charOffset="38:42" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.81.e.1" text="urea" type="Biomedical_Entity"><Normalization><mmtx cui="C0041942" phraseText="an elevated blood urea nitrogen level," preferredWord="Urea" semType="bacs, phsu, orch"/><RxNorm RxCui="11002"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.81.e.0" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.81.e.1"/></sentence><sentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.89" text="Calcium excretion is decreased by thiazides. " type="negative"><entity charOffset="0:7" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.89.e.0" text="calcium" type="Biomedical_Entity"><Normalization><mmtx cui="C0006675" phraseText="Calcium excretion" preferredWord="Calcium" semType="bacs, phsu, elii"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="34:43" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.89.e.1" text="thiazides" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="decreased by thiazides." preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.89.e.0" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.89.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.94" lineNumber="96" text="Potassium-sparing agents should be used with caution in conjunction with angiotensin-converting enzyme (ACE) inhibitors due to an increased risk of hyperkalemia." type="regular"><entity charOffset="148:160" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.94.e.1" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="0:24" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.94.e.2" text="Potassium-sparing agents" type="Drug_Class"><Normalization><mmtx cui="C0597277" phraseText="Potassium-sparing agents" preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C1254351" phraseText="Potassium-sparing agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="1437061"/></Normalization></entity><entity charOffset="73:119" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.94.e.3" text="angiotensin-converting enzyme (ACE) inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="in conjunction with angiotensin-converting enzyme (ACE) inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="6162"/></Normalization></entity><drugInteraction id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.94.ddi.1"><interaction trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.94.e.1"><relations><relation type="hasObject"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.94.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.94.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.94.e.2" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.94.e.3" trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.94.e.1" type="Specific_Interaction"/></sentence><sentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.95" text="Oral Hypoglycemic Drugs" type="negative"><entity charOffset="5:23" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.95.e.0" text="hypoglycemic drugs" type="Biomedical_Entity"><Normalization><mmtx cui="C0020616" phraseText="Oral Hypoglycemic Drugs" preferredWord="Hypoglycemic Agents" semType="phsu"/><RxNorm RxCui="5604"/></Normalization></entity><entity charOffset="0:17" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.95.e.1" text="oral hypoglycemic" type="Biomedical_Entity"><Normalization><mmtx cui="C0359086" phraseText="Oral Hypoglycemic Drugs" preferredWord="Oral hypoglycemic" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.95.e.1" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.95.e.0"/></sentence><sentence biomedicalEntities="1" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.96" lineNumber="100" text="Concurrent use with chlorpropamide may increase the risk of severe hyponatremia." type="irregular"><entity charOffset="67:79" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.96.e.1" text="hyponatremia" type="Specific_Interaction"><Normalization><mmtx cui="C0857122" phraseText="the risk of severe hyponatremia." preferredWord="hyponatremic" semType="dsyn"/></Normalization></entity><entity charOffset="20:34" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.96.e.2" text="chlorpropamide" type="Drug"><Normalization><mmtx cui="C0008287" phraseText="Concurrent use with chlorpropamide" preferredWord="Chlorpropamide" semType="phsu, orch"/><RxNorm RxCui="2404"/></Normalization></entity><drugInteraction id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.96.ddi.1"><interaction trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.96.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.96.e.2"/></relation><relation type="hasObject"><labelDrug text="DYAZIDE"/><normalization><mmtx><preferredWord>Dyazide</preferredWord><phraseText>DYAZIDE</phraseText><cuiCode>C0058829</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.96.e.2"/></sentence><sentence biomedicalEntities="3" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.98" lineNumber="104" text="A possible interaction resulting in acute renal failure has been reported in a few patients on DYAZIDE when treated with indomethacin, a nonsteroidal anti-inflammatory agent. " type="regular"><entity charOffset="137:173" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.98.e.1" text="nonsteroidal anti-inflammatory agent" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="a nonsteroidal anti-inflammatory agent." preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><mmtx cui="C3536840" phraseText="a nonsteroidal anti-inflammatory agent." preferredWord="Nonsteroidal Anti-inflammatory Drug [EPC]" semType="phsu"/><RxNorm RxCui="402125"/></Normalization></entity><entity charOffset="121:133" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.98.e.2" text="indomethacin" type="Drug"><Normalization><mmtx cui="C0021246" phraseText="treated with indomethacin," preferredWord="Indomethacin" semType="phsu, orch"/><RxNorm RxCui="5781"/></Normalization></entity><entity charOffset="36:55" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.98.e.4" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="resulting in acute renal failure" preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><entity charOffset="95:102" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.98.e.5" text="DYAZIDE" type="Drug"><Normalization><mmtx cui="C0058829" phraseText="on DYAZIDE" preferredWord="Dyazide" semType="phsu, orch"/><RxNorm RxCui="23742"/></Normalization></entity><entity charOffset="79:91" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.98.e.6" text="few patients" type="SPAN"/><drugClassMembership drug="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.98.e.2" drugClass="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.98.e.1"/><drugInteraction id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.98.ddi.1"><interaction trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.98.e.4"><relations><relation type="hasObject"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.98.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.98.e.2"/></relation><relation type="hasEvidence"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.98.e.6"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.98.e.5" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.98.e.2" evidence="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.98.e.6" trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.98.e.4" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.99" lineNumber="104" text="Caution is advised in administering nonsteroidal anti-inflammatory agents with DYAZIDE." type="regular"><entity charOffset="0:7" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.99.e.1" text="Caution" type="Caution_Interaction"/><entity charOffset="36:73" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.99.e.2" text="nonsteroidal anti-inflammatory agents" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="advised in administering nonsteroidal anti-inflammatory agents" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="402125"/></Normalization></entity><entity charOffset="79:86" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.99.e.3" text="DYAZIDE" type="Drug"><Normalization><mmtx cui="C0058829" phraseText="with DYAZIDE." preferredWord="Dyazide" semType="phsu, orch"/><RxNorm RxCui="23742"/></Normalization></entity><drugInteraction id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.99.ddi.1"><interaction trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.99.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.99.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.99.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.99.e.2" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.99.e.3" trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.99.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.101" lineNumber="108" text="Lithium generally should not be given with diuretics because they reduce its renal clearance and increase the risk of lithium toxicity. " type="regular"><anaphoraRelation><anaphoraEntity charOffset="61:65" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.101.e.3" text="they" type="Expression"/><antecedentEntity charOffset="43-52" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.101.e.8" text="diuretics" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><anaphoraEntity charOffset="73:76" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.101.e.2" text="its" type="Expression"/><antecedentEntity charOffset="0-7" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.101.e.10" text="Lithium" type="Drug"/></anaphoraRelation><entity charOffset="66:72|77:92" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.101.e.1" text="reduce renal clearance" type="Increase_Interaction"/><entity charOffset="126:134" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.101.e.5" text="toxicity" type="Increase_Interaction"/><entity charOffset="118:125" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.101.e.6" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="the risk of lithium toxicity." preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="43:52" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.101.e.8" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="given with diuretics" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="0:7" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.101.e.10" text="Lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="Lithium generally" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.101.ddi.1"><interaction trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.101.e.1"><relations><relation type="hasObject"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.101.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.101.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.101.ddi.2"><interaction trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.101.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.101.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.101.e.6"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.101.e.3" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.101.e.2" trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.101.e.1" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.101.e.3" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.101.e.6" trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.101.e.5" type="Increase_Interaction"/></sentence><sentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.102" text="Read circulars for lithium preparations before use of such concomitant therapy with DYAZIDE." type="negative"><entity charOffset="84:91" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.102.e.0" text="dyazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0058829" phraseText="with DYAZIDE." preferredWord="Dyazide" semType="phsu, orch"/><RxNorm RxCui="23742"/></Normalization></entity><entity charOffset="19:26" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.102.e.1" text="lithium" type="Biomedical_Entity"><Normalization><mmtx cui="C0023870" phraseText="Read circulars for lithium preparations" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.102.e.1" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.102.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.104" lineNumber="112" text="Thiazides have been shown to decrease arterial responsiveness to norepinephrine (an effect attributed to loss of sodium). " type="regular"><entity charOffset="29:61" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.104.e.1" text="decrease arterial responsiveness" type="Specific_Interaction"/><entity charOffset="0:9" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.104.e.2" text="Thiazides" type="Drug_Class"><Normalization><mmtx cui="C0541746" phraseText="Thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="65:79" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.104.e.3" text="norepinephrine" type="Drug"><Normalization><mmtx cui="C0028351" phraseText="arterial responsiveness to norepinephrine" preferredWord="Norepinephrine" semType="phsu, orch, nsba"/><RxNorm RxCui="7508"/></Normalization></entity><entity charOffset="105:119" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.104.e.5" text="loss of sodium" type="Specific_Interaction"/><drugInteraction id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.104.ddi.1"><interaction trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.104.e.1"><relations><relation type="hasObject"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.104.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.104.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.104.ddi.2"><interaction trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.104.e.5"><relations><relation type="hasObject"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.104.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.104.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.104.e.2" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.104.e.3" trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.104.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.106" lineNumber="112" text="Thiazides have also been shown to increase the paralyzing effect of nondepolarizing muscle relaxants such as tubocurarine (an effect attributed to potassium loss), consequently caution should be observed in patients undergoing surgery." type="regular"><entity charOffset="34:64" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.106.e.1" text="increase the paralyzing effect" type="Specific_Interaction"/><entity charOffset="0:9" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.106.e.2" text="Thiazides" type="Drug_Class"><Normalization><mmtx cui="C0541746" phraseText="Thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="68:100" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.106.e.3" text="nondepolarizing muscle relaxants" type="Drug_Class"><Normalization><mmtx cui="C0010464" phraseText="the paralyzing effect of nondepolarizing muscle relaxants" preferredWord="Neuromuscular Nondepolarizing Agents" semType="phsu"/><RxNorm RxCui="91172"/></Normalization></entity><entity charOffset="109:121" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.106.e.5" text="tubocurarine" type="Drug"><Normalization><mmtx cui="C0041345" phraseText="such as tubocurarine" preferredWord="Tubocurarine" semType="phsu, orch"/><RxNorm RxCui="82115"/></Normalization></entity><entity charOffset="147:161" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.106.e.7" text="potassium loss" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.106.e.5" drugClass="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.106.e.3"/><drugInteraction id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.106.ddi.1"><interaction trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.106.e.1"><relations><relation type="hasObject"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.106.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.106.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.106.ddi.2"><interaction trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.106.e.7"><relations><relation type="hasObject"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.106.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.106.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.106.e.2" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.106.e.3" trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.106.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.108" lineNumber="116" text="Concurrent use of hydrochlorothiazide with amphotericin B or corticosteroids or corticotropin (ACTH) may intensify electrolyte imbalance, particularly hypokalemia, although the presence of triamterene minimizes the hypokalemic effect." type="regular"><entity charOffset="151:162" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.108.e.1" text="hypokalemia" type="Specific_Interaction"/><entity charOffset="61:76" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.108.e.2" text="corticosteroids" type="Drug_Class"><Normalization><mmtx cui="C0001617" phraseText="corticosteroids" preferredWord="Adrenal Cortex Hormones" semType="strd, phsu, horm"/><RxNorm RxCui="1427675"/></Normalization></entity><entity charOffset="18:37" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.108.e.3" text="hydrochlorothiazide" type="Drug"><Normalization><mmtx cui="C0020261" phraseText="Concurrent use of hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="80:100" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.108.e.4" text="corticotropin (ACTH)" type="Drug"><Normalization><mmtx cui="C0001655" phraseText="corticotropin" preferredWord="Corticotropin" semType="phsu, aapp, horm, nsba"/><mmtx cui="C1523997" phraseText="corticotropin" preferredWord="Recombinant Corticotropin" semType="phsu, aapp, horm"/><RxNorm RxCui="376"/></Normalization></entity><entity charOffset="43:57" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.108.e.5" text="amphotericin B" type="Drug"><Normalization><mmtx cui="C0002679" phraseText="with amphotericin B" preferredWord="Amphotericin B" semType="orch, antb"/><RxNorm RxCui="732"/></Normalization></entity><entity charOffset="105:136" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.108.e.7" text="intensify electrolyte imbalance" type="Specific_Interaction"><Normalization><mmtx cui="C1397014" phraseText="electrolyte imbalance," preferredWord="Imbalance" semType="sosy"/><mmtx cui="C1397014" phraseText="electrolyte imbalance," preferredWord="Imbalance" semType="sosy"/></Normalization></entity><drugInteraction id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.108.ddi.1"><interaction trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.108.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.108.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.108.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.108.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.108.e.4"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.108.ddi.2"><interaction trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.108.e.7"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.108.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.108.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.108.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.108.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.108.e.3" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.108.e.2" trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.108.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.108.e.3" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.108.e.5" trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.108.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.108.e.3" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.108.e.4" trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.108.e.1" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.108.e.5" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.108.e.2"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.108.e.2" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.108.e.4"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.108.e.5" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.108.e.4"/></sentence><sentence biomedicalEntities="2" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.109" lineNumber="117" text="Thiazides may add to or potentiate the action of other antihypertensive drugs. " type="regular"><entity charOffset="14:20|35:45" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.109.e.1" text="add to the action" type="Increase_Interaction"/><entity charOffset="0:9" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.109.e.2" text="Thiazides" type="Drug_Class"><Normalization><mmtx cui="C0541746" phraseText="Thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="55:77" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.109.e.3" text="antihypertensive drugs" type="Drug_Class"><Normalization><mmtx cui="C0003364" phraseText="the action of other antihypertensive drugs." preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="24:45" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.109.e.5" text="potentiate the action" type="Increase_Interaction"/><drugInteraction id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.109.ddi.1"><interaction trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.109.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.109.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.109.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.109.ddi.2"><interaction trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.109.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.109.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.109.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.109.e.2" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.109.e.3" trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.109.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.111" lineNumber="118" text="The effect of oral anticoagulants may be decreased when used concurrently with hydrochlorothiazide, dosage adjustments may be necessary." type="regular"><entity charOffset="4:10|41:50" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.111.e.1" text="effect decreased" type="Decrease_Interaction"/><entity charOffset="79:98" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.111.e.2" text="hydrochlorothiazide" type="Drug"><Normalization><mmtx cui="C0020261" phraseText="concurrently with hydrochlorothiazide," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="14:33" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.111.e.3" text="oral anticoagulants" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="100:118" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.111.e.5" text="dosage adjustments" type="Caution_Interaction"/><drugInteraction id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.111.ddi.1"><interaction trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.111.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.111.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.111.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.111.ddi.2"><interaction trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.111.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.111.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.111.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.111.e.3" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.111.e.2" trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.111.e.1" type="Decrease_Interaction"/><pair ddi="true" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.111.e.3" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.111.e.2" trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.111.e.5" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.112" lineNumber="119" text="DYAZIDE may raise the level of blood uric acid, dosage adjustments of antigout medication may be necessary to control hyperuricemia and gout." type="regular"><entity charOffset="48:66" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.112.e.1" text="dosage adjustments" type="Caution_Interaction"/><entity charOffset="0:7" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.112.e.2" text="DYAZIDE" type="Drug"><Normalization><mmtx cui="C0058829" phraseText="DYAZIDE" preferredWord="Dyazide" semType="phsu, orch"/><RxNorm RxCui="23742"/></Normalization></entity><entity charOffset="70:89" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.112.e.3" text="antigout medication" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="dosage adjustments of antigout medication" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="4994"/></Normalization></entity><drugInteraction id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.112.ddi.1"><interaction trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.112.e.1"><relations><relation type="hasObject"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.112.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.112.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.112.e.2" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.112.e.3" trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.112.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="6" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113" lineNumber="120" text="The following agents given together with triamterene may promote serum potassium accumulation and possibly result in hyperkalemia because of the potassium-sparing nature of triamterene, especially in patients with renal insufficiency: blood from blood bank (may contain up to 30 mEq of potassium per liter of plasma or up to 65 mEq per liter of whole blood when stored for more than 10 days), low-salt milk (may contain up to 60 mEq of potassium per liter), potassium-containing medications (such as parenteral penicillin G potassium), salt substitutes (most contain substantial amounts of potassium)." type="regular"><entity charOffset="65:93" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.1" text="serum potassium accumulation" type="Specific_Interaction"/><entity charOffset="41:52" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.2" text="triamterene" type="Drug"><Normalization><mmtx cui="C0040869" phraseText="given together with triamterene" preferredWord="Triamterene" semType="phsu, orch"/><RxNorm RxCui="10763"/></Normalization></entity><entity charOffset="235:256" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.3" text="blood from blood bank" type="Substance"><Normalization><RxNorm RxCui="1629"/></Normalization></entity><entity charOffset="536:552" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.4" text="salt substitutes" type="Substance"><Normalization><mmtx cui="C0784217" phraseText="salt substitutes" preferredWord="Salt Substitute" semType="inch, phsu"/><RxNorm RxCui="9547"/></Normalization></entity><entity charOffset="214:233" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.5" text="renal insufficiency" type="SPAN"><Normalization><mmtx cui="C0035078" phraseText="with renal insufficiency" preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C1565489" phraseText="with renal insufficiency" preferredWord="Renal Insufficiency" semType="dsyn"/></Normalization></entity><entity charOffset="393:406" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.6" text="low-salt milk" type="Substance"><Normalization><mmtx cui="C0037494" phraseText="low-salt milk" preferredWord="Sodium Chloride" semType="bacs, inch, phsu"/><RxNorm RxCui="1023523"/></Normalization></entity><entity charOffset="458:490" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.7" text="potassium-containing medications" type="Drug_Class"><Normalization><mmtx cui="C0597277" phraseText="potassium-containing medications" preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C0013227" phraseText="potassium-containing medications" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="117:129" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.9" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="500:533" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.11" text="parenteral penicillin G potassium" type="Drug"><Normalization><mmtx cui="C0700462" phraseText="such as parenteral penicillin G potassium" preferredWord="Penicillin G Potassium" semType="orch, antb"/><RxNorm RxCui="107735"/></Normalization></entity><drugClassMembership drug="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.11" drugClass="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.7"/><drugInteraction id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.ddi.1"><interaction trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.1"><relations><relation type="hasObject"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.4"/></relation><relation type="hasContext"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.6"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.7"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.ddi.2"><interaction trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.9"><relations><relation type="hasObject"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.4"/></relation><relation type="hasContext"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.6"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.7"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.5" ddi="true" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.2" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.3" trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.1" type="Specific_Interaction"/><pair context="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.5" ddi="true" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.2" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.4" trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.1" type="Specific_Interaction"/><pair context="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.5" ddi="true" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.2" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.6" trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.1" type="Specific_Interaction"/><pair context="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.5" ddi="true" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.2" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.7" trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.1" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.3" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.4"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.3" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.6"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.3" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.7"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.6" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.4"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.7" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.4"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.6" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.113.e.7"/></sentence><sentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.114" text="Exchange resins, such as sodium polystyrene sulfonate, whether administered orally or rectally, reduce serum potassium levels by sodium replacement of the potassium, fluid retention may occur in some patients because of the increased sodium intake." type="negative"><entity charOffset="109:118" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.114.e.0" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="serum potassium levels by sodium replacement of the potassium," preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="129:135" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.114.e.1" text="sodium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597484" phraseText="serum potassium levels by sodium replacement of the potassium," preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="1444874"/></Normalization></entity><entity charOffset="25:53" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.114.e.2" text="sodium polystyrene sulfonate" type="Biomedical_Entity"><Normalization><mmtx cui="C0142915" phraseText="such as sodium polystyrene sulfonate," preferredWord="Sodium polystyrene sulfonate" semType="phsu, orch"/><RxNorm RxCui="9853"/></Normalization></entity><entity charOffset="234:240" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.114.e.3" text="sodium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597484" phraseText="because of the increased sodium intake." preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="1444874"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.114.e.0" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.114.e.1"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.114.e.2" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.114.e.0"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.114.e.0" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.114.e.3"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.114.e.2" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.114.e.1"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.114.e.2" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.114.e.3"/></sentence><sentence biomedicalEntities="2" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.115" lineNumber="122" text="Chronic or overuse of laxatives may reduce serum potassium levels by promoting excessive potassium loss from the intestinal tract, laxatives may interfere with the potassium-retaining effects of triamterene." type="regular"><entity charOffset="145:191" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.115.e.1" text="interfere with the potassium-retaining effects" type="Specific_Interaction"/><entity charOffset="131:140" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.115.e.2" text="laxatives" type="Drug_Class"><Normalization><mmtx cui="C0282090" phraseText="laxatives" preferredWord="Laxatives" semType="phsu"/><RxNorm RxCui="81973"/></Normalization></entity><entity charOffset="195:206" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.115.e.3" text="triamterene" type="Drug"><Normalization><mmtx cui="C0040869" phraseText="interfere with the potassium-retaining effects of triamterene." preferredWord="Triamterene" semType="phsu, orch"/><RxNorm RxCui="10763"/></Normalization></entity><drugInteraction id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.115.ddi.1"><interaction trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.115.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.115.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.115.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.115.e.2" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.115.e.3" trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.115.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.116" lineNumber="123" text="The effectiveness of methenamine may be decreased when used concurrently with hydrochlorothiazide because of alkalinization of the urine." type="regular"><entity charOffset="4:17|40:49" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.116.e.1" text="effectiveness decreased" type="Decrease_Interaction"/><entity charOffset="78:97" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.116.e.2" text="hydrochlorothiazide" type="Drug"><Normalization><mmtx cui="C0020261" phraseText="concurrently with hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="21:32" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.116.e.3" text="methenamine" type="Drug"><Normalization><mmtx cui="C0025638" phraseText="The effectiveness of methenamine" preferredWord="Methenamine" semType="phsu, orch"/><RxNorm RxCui="6832"/></Normalization></entity><drugInteraction id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.116.ddi.1"><interaction trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.116.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.116.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.116.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.116.e.3" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.116.e.2" trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.116.e.1" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.118" lineNumber="127" text="Triamterene and quinidine have similar fluorescence spectra, thus, DYAZIDE will interfere with the fluorescent measurement of quinidine." type="regular"><entity charOffset="80:122" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.118.e.1" text="interfere with the fluorescent measurement" type="Specific_Interaction"/><entity charOffset="67:74" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.118.e.2" text="DYAZIDE" type="Drug"><Normalization><mmtx cui="C0058829" phraseText="DYAZIDE" preferredWord="Dyazide" semType="phsu, orch"/><RxNorm RxCui="23742"/></Normalization></entity><entity charOffset="126:135" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.118.e.3" text="quinidine" type="Drug"><Normalization><mmtx cui="C0034414" phraseText="interfere with the fluorescent measurement of quinidine." preferredWord="Quinidine" semType="phsu, orch"/><RxNorm RxCui="9068"/></Normalization></entity><drugInteraction id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.118.ddi.1"><interaction trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.118.e.1"><relations><relation type="hasObject"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.118.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.118.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.118.e.2" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.118.e.3" trigger="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.118.e.1" type="Specific_Interaction"/></sentence><sentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.121" text="Long-term studies have not been conducted with DYAZIDE (the triamterene/hydrochlorothiazide combination), or with triamterene alone." type="negative"><entity charOffset="114:125" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.121.e.0" text="triamterene" type="Biomedical_Entity"><Normalization><mmtx cui="C0040869" phraseText="or with triamterene" preferredWord="Triamterene" semType="phsu, orch"/><RxNorm RxCui="10763"/></Normalization></entity><entity charOffset="47:54" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.121.e.1" text="dyazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0058829" phraseText="conducted with DYAZIDE" preferredWord="Dyazide" semType="phsu, orch"/><RxNorm RxCui="23742"/></Normalization></entity><entity charOffset="60:91" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.121.e.2" text="triamterene/hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0813211" phraseText="the triamterene/hydrochlorothiazide combination" preferredWord="hydrochlorothiazide-triamterene" semType="phsu, orch"/><RxNorm RxCui="258337"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.121.e.1" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.121.e.0"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.121.e.2" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.121.e.0"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.121.e.1" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.121.e.2"/></sentence><sentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.124" text="On a body-weight basis, these doses are 600 times (in mice) and 100 times (in rats) the Maximum Recommended Human Dose (MRHD) for the hydrochlorothiazide component of DYAZIDE at 50 mg/day (or 1.0 mg/kg/day based on 50 kg individuals). " type="negative"><entity charOffset="134:153" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.124.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="for the hydrochlorothiazide component" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="17:22" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.124.e.1" text="basis" type="Biomedical_Entity"><Normalization><mmtx cui="C1874451" phraseText="On a body-weight basis," preferredWord="Basis" semType="phsu"/><RxNorm RxCui="1046801"/></Normalization></entity><entity charOffset="167:174" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.124.e.2" text="dyazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0058829" phraseText="of DYAZIDE" preferredWord="Dyazide" semType="phsu, orch"/><RxNorm RxCui="23742"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.124.e.1" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.124.e.0"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.124.e.0" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.124.e.2"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.124.e.1" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.124.e.2"/></sentence><sentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.128" text="Studies of the mutagenic potential of DYAZIDE (the triamterene/hydrochlorothiazide combination), or of triamterene alone have not been performed." type="negative"><entity charOffset="103:114" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.128.e.0" text="triamterene" type="Biomedical_Entity"><Normalization><mmtx cui="C0040869" phraseText="or of triamterene" preferredWord="Triamterene" semType="phsu, orch"/><RxNorm RxCui="10763"/></Normalization></entity><entity charOffset="51:82" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.128.e.1" text="triamterene/hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0813211" phraseText="the triamterene/hydrochlorothiazide combination" preferredWord="hydrochlorothiazide-triamterene" semType="phsu, orch"/><RxNorm RxCui="258337"/></Normalization></entity><entity charOffset="38:45" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.128.e.2" text="dyazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0058829" phraseText="Studies of the mutagenic potential of DYAZIDE" preferredWord="Dyazide" semType="phsu, orch"/><RxNorm RxCui="23742"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.128.e.1" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.128.e.0"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.128.e.2" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.128.e.0"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.128.e.2" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.128.e.1"/></sentence><sentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.133" text="Studies of the effects of DYAZIDE (the triamterene/hydrochlorothiazide combination), or of triamterene alone on animal reproductive function have not been conducted." type="negative"><entity charOffset="26:33" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.133.e.0" text="dyazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0058829" phraseText="Studies of the effects of DYAZIDE" preferredWord="Dyazide" semType="phsu, orch"/><RxNorm RxCui="23742"/></Normalization></entity><entity charOffset="91:102" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.133.e.1" text="triamterene" type="Biomedical_Entity"><Normalization><mmtx cui="C0040869" phraseText="or of triamterene" preferredWord="Triamterene" semType="phsu, orch"/><RxNorm RxCui="10763"/></Normalization></entity><entity charOffset="39:70" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.133.e.2" text="triamterene/hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0813211" phraseText="the triamterene/hydrochlorothiazide combination" preferredWord="hydrochlorothiazide-triamterene" semType="phsu, orch"/><RxNorm RxCui="258337"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.133.e.0" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.133.e.1"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.133.e.0" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.133.e.2"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.133.e.2" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.133.e.1"/></sentence><sentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.140" text="However, a One Generation Study in the rat approximated composition of DYAZIDE by using a 1:1 ratio of triamterene to hydrochlorothiazide (30:30 mg/kg/day), there was no evidence of teratogenicity at those doses which were, on a body-weight basis, 15 and 30 times, respectively, the MRHD, and on the basis of body-surface area, 3.1 and 6.2 times, respectively, the MRHD." type="negative"><entity charOffset="241:246" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.140.e.0" text="basis" type="Biomedical_Entity"><Normalization><mmtx cui="C1874451" phraseText="on a body-weight basis," preferredWord="Basis" semType="phsu"/><RxNorm RxCui="1046801"/></Normalization></entity><entity charOffset="103:114" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.140.e.1" text="triamterene" type="Biomedical_Entity"><Normalization><mmtx cui="C0040869" phraseText="1 ratio of triamterene" preferredWord="Triamterene" semType="phsu, orch"/><RxNorm RxCui="10763"/></Normalization></entity><entity charOffset="118:137" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.140.e.2" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="to hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="300:305" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.140.e.3" text="basis" type="Biomedical_Entity"><Normalization><mmtx cui="C1874451" phraseText="and on the basis of body-surface area," preferredWord="Basis" semType="phsu"/><RxNorm RxCui="1046801"/></Normalization></entity><entity charOffset="71:78" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.140.e.4" text="dyazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0058829" phraseText="a One Generation Study in the rat approximated composition of DYAZIDE" preferredWord="Dyazide" semType="phsu, orch"/><RxNorm RxCui="23742"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.140.e.1" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.140.e.0"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.140.e.2" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.140.e.0"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.140.e.4" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.140.e.0"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.140.e.1" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.140.e.2"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.140.e.1" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.140.e.3"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.140.e.4" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.140.e.1"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.140.e.2" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.140.e.3"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.140.e.4" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.140.e.2"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.140.e.4" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.140.e.3"/></sentence><sentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.144" text="Reproduction studies have been performed in rats at doses as high as 20 times the MRHD on the basis of body-weight, and 6 times the human dose on the basis of body-surface area without evidence of harm to the fetus due to triamterene." type="negative"><entity charOffset="222:233" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.144.e.0" text="triamterene" type="Biomedical_Entity"><Normalization><mmtx cui="C0040869" phraseText="due to triamterene." preferredWord="Triamterene" semType="phsu, orch"/><RxNorm RxCui="10763"/></Normalization></entity><entity charOffset="150:155" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.144.e.1" text="basis" type="Biomedical_Entity"><Normalization><mmtx cui="C1874451" phraseText="the human dose on the basis of body-surface area" preferredWord="Basis" semType="phsu"/><RxNorm RxCui="1046801"/></Normalization></entity><entity charOffset="94:99" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.144.e.2" text="basis" type="Biomedical_Entity"><Normalization><mmtx cui="C1874451" phraseText="the MRHD on the basis of body-weight," preferredWord="Basis" semType="phsu"/><RxNorm RxCui="1046801"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.144.e.1" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.144.e.0"/><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.144.e.2" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.144.e.0"/></sentence><sentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.151" text="Thiazides and triamterene have been shown to cross the placental barrier and appear in cord blood. " type="negative"><entity charOffset="14:25" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.151.e.0" text="triamterene" type="Biomedical_Entity"><Normalization><mmtx cui="C0040869" phraseText="triamterene" preferredWord="Triamterene" semType="phsu, orch"/><RxNorm RxCui="10763"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.151.e.1" text="thiazides" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="Thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.151.e.1" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.151.e.0"/></sentence><sentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.152" text="The use of thiazides and triamterene in pregnant women requires that the anticipated benefit be weighed against possible hazards to the fetus. " type="negative"><entity charOffset="25:36" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.152.e.0" text="triamterene" type="Biomedical_Entity"><Normalization><mmtx cui="C0040869" phraseText="triamterene in pregnant women" preferredWord="Triamterene" semType="phsu, orch"/><RxNorm RxCui="10763"/></Normalization></entity><entity charOffset="11:20" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.152.e.1" text="thiazides" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="The use of thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.152.e.1" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.152.e.0"/></sentence><sentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.155" text="Thiazides and triamterene in combination have not been studied in nursing mothers. " type="negative"><entity charOffset="0:9" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.155.e.0" text="thiazides" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="Thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="14:25" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.155.e.1" text="triamterene" type="Biomedical_Entity"><Normalization><mmtx cui="C0040869" phraseText="triamterene in combination" preferredWord="Triamterene" semType="phsu, orch"/><RxNorm RxCui="10763"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.155.e.0" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.155.e.1"/></sentence><sentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.157" text="Thiazides are excreted in human breast milk. " type="negative"><entity charOffset="0:9" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.157.e.0" text="thiazides" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="Thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="26:43" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.157.e.1" text="human breast milk" type="Biomedical_Entity"><Normalization><mmtx cui="C0885503" phraseText="excreted in human breast milk." preferredWord="human breast milk" semType="phsu, orch"/><RxNorm RxCui="831503"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.157.e.0" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.157.e.1"/></sentence><sentence id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.158" text="If use of the combination drug product is deemed essential, the patient should stop nursing." type="negative"><entity charOffset="26:38" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.158.e.0" text="drug product" type="Biomedical_Entity"><Normalization><mmtx cui="C0013227" phraseText="use of the combination drug product" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="14:30" id="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.158.e.1" text="combination drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0013162" phraseText="use of the combination drug product" preferredWord="Drug Combinations" semType="phsu"/><RxNorm RxCui="1429321"/></Normalization></entity><pair ddi="false" e1="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.158.e.1" e2="Dailymed.f6eba4b6-9cd0-4c86-46a8-05a202641c89.s.158.e.0"/></sentence><positiveExamples number="28"/><negativeExamples number="96"/></document>